Share price
₹2,539.4 latest close · +24.6% over the last 90 sessions
52-week range ₹1336.60 to ₹2719.30 · 1-year volatility 32.7%
How rough has the ride been?
Drawdown from peak
Most recent volume spikes
2026-11-09: 7.4x the 50-day median, price +0.2% that day
2026-11-06: 6.8x the 50-day median, price +2.6% that day
2026-11-04: 11.6x the 50-day median, price +5.9% that day
Where does it rank among Health Technology peers?
Each cell is the company's percentile rank among its Health Technology peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Where it ranks today
- ROCE91st
- Op. margin67th
- Debt/equity ↓52nd
- Cash cycle ↓93rd
- P/E ↓17th
Rank history
Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.
The Health Technology sector page Watch it move against Health Technology in the Observatory
What is the price implying?
At a P/E of 121.4x, the price would imply about 36.9%/yr earnings growth for 10 years under the same assumptions, but it is not ranked.
Fewer than six years of annual earnings are available, which is too little to measure delivered growth.
“Implied growth” is what the current price would require under our stated assumptions, not what we expect.
What prices imply across Health Technology The market-wide Expectations lists
Key figures
- Share Priceclose 9 Nov
- ₹2539.40
- P/E
- 78.0x
- ROCE
- 33.0%
- Market Cap
- ₹15528 cr
- Revenue (TTM)
- ₹1478 cr
- P/S
- 10.5x
- P/B
- 20.8x
- ROE
- 26.6%
- Operating Margin
- 22.0%
- Debt / Equity
- 0.2x
- Promoter Holding
- 69.0%
52-week range
Price risk
Balance sheet & cash
Are profits backed by cash?
Other income reliance-3%Within range
Other income as a share of pre-tax profit (trailing twelve months): -3.1%. Bands: below 15%, 15% to 35%, above 35%.
Tax rate25%Within range
Median quarterly effective tax rate over about 2.5 years: 25.0%. Bands: 15% to 35%, 5% to 15% or 35% to 50%, outside 5% to 50%.
Cash conversion1.36xWithin range
Operating cash flow divided by net profit over the last three fiscal years: 1.36x (cash from operations ₹576 cr, net profit ₹424 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.
Free cash flow3 of 4 yrsNear threshold
Fiscal years with positive free cash flow in the last 4: 3. Bands: at least 80% of years, 40% to 80%, below 40%.
Receivable days vs history—Not enough data
Not enough reported data to compute this.
Capital work in progress26% of fixed assetsWithin range
Capital work-in-progress is 26% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.
Payable days—Not enough data
Not enough reported data to compute this.
Tap a check to see how it is measured
How to read this
Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.
What else looks like this?
Companies with the most similar financial profile today, regardless of industry.
Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.
What changed?
4 events since Jun '26
- NovPriceVolume reached 11.6x its 50-day median on 2026-11-04; price +5.9% that day.
- SepInstitutionsFII + DII holding rose 7.9 pts over 2 quarters to 16.5%.
- SepPriceVolume reached 16.6x its 50-day median on 2026-09-10; price +0.2% that day.
- JunPriceVolume reached 16.8x its 50-day median on 2026-06-17; price +2.4% that day.
Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.
Where price and fundamentals disagree, market-wide Rewind the whole market to any month
Monthly history12 months · 2025-12 to 2026-11
| Month | P/E | Revenue (TTM) | ROE | ROCE | Debt / Equity |
|---|---|---|---|---|---|
| 2026-11 | 78.0x | ₹1478 cr | 26.6% | 33.0% | 0.2x |
| 2026-10 | 66.1x | ₹1478 cr | 26.5% | 33.0% | 0.2x |
| 2026-09 | 64.3x | ₹1478 cr | 26.5% | 33.0% | 0.2x |
| 2026-08 | 67.8x | ₹1403 cr | 24.6% | 33.0% | 0.2x |
| 2026-07 | 69.4x | ₹1403 cr | 24.6% | 33.0% | 0.2x |
| 2026-06 | 65.0x | ₹1403 cr | 24.6% | 33.0% | 0.2x |
| 2026-05 | 59.9x | ₹1344 cr | 28.2% | 32.0% | 0.1x |
| 2026-04 | 61.6x | ₹1344 cr | 28.2% | 32.0% | 0.1x |
| 2026-03 | 55.6x | ₹1344 cr | 28.2% | 32.0% | 0.1x |
| 2026-02 | 55.5x | ₹1300 cr | 28.9% | 32.0% | 0.1x |
| 2026-01 | 51.7x | ₹1300 cr | 28.9% | 32.0% | 0.1x |
| 2025-12 | 48.4x | ₹1300 cr | 28.9% | 32.0% | 0.1x |